Neurofibromatosis (NF) is treated by a team of specialists rather than a single doctor. Because the condition can affect the skin, bones, eyes, brain, and nerves, no one specialty covers everything. The core team typically includes neurologists, geneticists, neurosurgeons, and neuro-oncologists, with additional specialists brought in depending on which parts of the body are involved.
Why NF Requires a Team Approach
Neurofibromatosis causes tumors to grow along nerves throughout the body. These tumors can appear in the brain, along the spine, beneath the skin, or around the eyes. They can press on surrounding structures and cause pain, vision loss, hearing changes, or bone abnormalities. Because the condition touches so many organ systems, a coordinated group of specialists works together to monitor and manage it over a lifetime.
Major medical centers organize these specialists into multidisciplinary NF clinics where you can see several providers in one visit. The Children’s Tumor Foundation maintains an NF Clinic Network that designates centers based on patient volume, research involvement, and breadth of expertise. Centers earning “Comprehensive Center” status offer higher patient volumes, on-site research, and expanded education. “Specialty Programs” demonstrate NF expertise with a focus on clinical care. If you don’t live near a designated center, a local neurologist or neuro-oncologist can coordinate your care with guidance from a specialized team.
Neurologists and Neuro-Oncologists
A neurologist is often the central figure in NF care, especially for NF1 (the most common form). They track tumor growth, manage neurological symptoms, and coordinate referrals to other specialists. Neuro-oncologists step in when tumors grow in ways that may need medication or closer monitoring. For NF1 patients with symptomatic plexiform neurofibromas (large, tangled nerve tumors that can’t be surgically removed), a neuro-oncologist may prescribe selumetinib, a targeted drug the FDA first approved for children ages one and older and extended to adults in late 2025.
Geneticists and Genetic Counselors
A clinical geneticist often makes or confirms the diagnosis. The revised diagnostic criteria, published in 2021 by an international consensus group, require at least two clinical features in someone without a family history. These include six or more café-au-lait spots (light brown skin patches), freckling in the armpits or groin, two or more neurofibromas, an optic pathway glioma, certain eye findings, distinctive bone abnormalities, or identification of a mutation in the NF1 gene. A child who has a parent already diagnosed with NF1 needs only one of these features.
Genetic counselors play a distinct role from geneticists. They help families understand what a diagnosis means in practical terms, walk through inheritance patterns, and support decision-making around family planning. NF1 follows autosomal dominant inheritance: if one parent carries the mutation, each child has a 50% chance of inheriting it. For couples who want to reduce that risk, counselors can discuss options like preimplantation genetic diagnosis during IVF, or using donor eggs or sperm from an unaffected individual. About half of all NF1 cases arise as new (de novo) mutations with no family history, so genetic testing of parents helps clarify whether a case is inherited or spontaneous.
Ophthalmologists
Eye doctors are critical in NF1 care because optic pathway gliomas, tumors along the nerves connecting the eyes to the brain, develop in roughly 15 to 20 percent of children with NF1. Current guidelines recommend yearly comprehensive eye exams for children with NF1 every year until age eight, then every other year until age 18. These exams go beyond a standard vision check: they include visual acuity measurements, visual field testing, color vision assessment, pupil response, and evaluation of the optic disc.
If an optic pathway glioma is found on MRI, the monitoring schedule tightens considerably. Eye exams move to every three months for the first year, then every six months for two more years, before eventually returning to annual checks if the tumor stays stable. Any sudden vision changes at any age should prompt an immediate exam regardless of the schedule.
Surgeons
Several surgical specialties may be involved depending on where tumors develop. Neurosurgeons handle tumors that involve the brain, spinal cord, or skull base. Plastic surgeons manage tumor removal and reconstruction for visible or disfiguring growths, particularly neurofibromas near the face or body surface. For complex cases like infiltrating tumors of the eye socket region that cause drooping eyelids, compress the optic nerve, or extend into the skull, ophthalmologic surgeons and neurosurgeons often collaborate.
A 25-year analysis of surgical management in NF1 patients found that plastic surgeons, ophthalmologists, neurosurgeons, and radiologists were the most actively involved surgical specialists. Many patients undergo multiple procedures over their lifetime, which is one reason coordinated care at a center familiar with NF is so valuable.
Pain and Rehabilitation Specialists
Chronic pain is one of the most common quality-of-life issues for people with NF. Pain management specialists help address nerve-related pain from tumor pressure, while physiatrists (doctors trained in physical and rehabilitation medicine) develop strategies for maintaining mobility and function. Rehabilitation experts, including physical and occupational therapists, round out supportive care. Centers like Memorial Sloan Kettering include all of these professionals as part of their NF team and review each patient’s progress regularly to adjust the plan.
Additional Specialists for NF2
NF2-related schwannomatosis (formerly called NF2) affects different structures than NF1 and requires its own set of specialists. The hallmark of NF2 is vestibular schwannomas, tumors on the nerves responsible for hearing and balance. Audiologists monitor hearing through pure-tone threshold tests and word recognition scores, assessments that take about 20 minutes and are widely available. Otolaryngologists (ENT surgeons) manage the tumors themselves, and facial function is tracked using a standardized grading scale because facial nerve weakness is a common consequence of both the tumors and their surgical removal.
The broader NF2 care team mirrors NF1 in many ways, pulling from neurology, genetics, oncology, radiology, and therapy services. But the emphasis shifts toward preserving hearing and facial function rather than monitoring skin tumors and vision.
Transitioning From Pediatric to Adult Care
NF is a lifelong condition, and one of the trickier moments in care comes when patients age out of pediatric clinics. Children’s hospitals tend to offer the “one-stop shop” model where multiple specialists see you on the same day. Adult care is more fragmented, often requiring separate appointments with each provider. The transition works best when pediatric providers identify adult counterparts early and perform a “warm handoff,” whether by phone, electronic message, or a joint telehealth visit. In areas without established adult NF clinics, the pediatric team may educate a local neurologist or neuro-oncologist to take over primary NF management.
If you or your child are approaching this transition, asking your current NF team about their transfer process and which adult providers they recommend can prevent gaps in surveillance during a period when monitoring still matters.